Cite
APA Citation
Foley, J., Xiong, K., Hoyt, T., Singh, C. M., Riddle, E., de Moor, C., Plavina, T., & Campbell, N. (2023). serum neurofilament light levels in natalizumab-treated patients with multiple sclerosis who switch to extended interval dosing from every-4-week dosing in real-world clinical practice. Multiple sclerosis, 29, 196–205. http://access.bl.uk/ark:/81055/vdc_100175891867.0x000015